Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $13.0300 (2.28%) ($12.4400 - $13.2900) on Thu. Jul. 30, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.74% (three month average) | RSI | 31 | Latest Price | $13.0300(2.28%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1.4% a day on average for past five trading days. | Weekly Trend | ATRA declines -2.1% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(44%) IBB(44%) ARKK(43%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -3.37% in a week (0% probabilities). VIXM(-31%) VXX(-26%) XLC(-10%) UNG(-9%) UUP(-8%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.37% (StdDev 6.74%) | Hourly BBV | 0 () | Intraday Trend | 3.7% | | | |
|
1 - 5 Day Possible Target | $2.24(-82.81%) | Resistance Level | $14 | 5 Day Moving Average | $13.28(-1.88%) | 10 Day Moving Average | $13.54(-3.77%) | 20 Day Moving Average | $14(-6.93%) | To recent high | -15.9% | To recent low | 64.5% | Market Cap | $968m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |